SOURCE: Universal Detection Technology

February 24, 2010 05:00 ET

Universal Detection Technology Working With U.S. Department of Commerce to Market Anthrax Detection Equipment in Australia

UNDT's Agreement With U.S. Commerce Department Will Supply Country With Equipment for Combating the Growing Threat of Bioterrorism

LOS ANGELES, CA--(Marketwire - February 24, 2010) -  Universal Detection Technology ( (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that through its agreement with U.S. Department of Commerce's Commercial Service, the company is promoting its handheld assays, used for detection of up to five bioterrorism agents, in Australia. UNDT is to be listed as a Featured U.S. Exporter on Commercial Service's Australia website.

UNDT's 5-agent bioterrorism detection kits have been used extensively by first responders and private industry throughout the United States. Testing of the kits by the U.S. DoD as well as the United Kingdom military show that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered "white powders." The kits are designed to test for anthrax, botulinum toxin, ricin, plague (Y. Pestis) and SEBs in as little as three minutes.

"Through our relationship with the U.S. Department of Commerce, we are working to expand our bio-weapons detection equipment offerings in countries that have been targeted by terrorists," said Universal Detection Technology CEO Jacques Tizabi. "We will continue to expand our international network through our relationship with the Department of Commerce," continued Tizabi.

To view UNDT's bioterrorism detection kits on the Commercial Service's website, please go to:

For more information please visit or email

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information